COMP <GO>
CTEV vs RPAY // REVENUE GROWTH (YOY)
Claritev Corporation (Class A) (NYSE) VS. Repay Holdings Corporation (Class A) (NASDAQ) • 15-METRIC TALLY: CTEV 5
— RPAY 3
▲ REVENUE GROWTH (YOY) LEADER: CTEV
LAST: $24.00 (+4.35%) • MKT CAP: $406.7M
revenue-growth
3.70%
LAST: $4.42 (0.00%) • MKT CAP: $397.2M
revenue-growth
-1.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTEV VS. RPAY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTEV | RPAY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 75.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | -31.00% | +116.00 | CTEV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 2.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.02% | 22.87% | -25.89 | RPAY | /fcf-yield <GO> |
| Operating Margin | 3.00% | -60.00% | +63.00 | CTEV | /operating-margins <GO> |
| Net Profit Margin | -29.40% | -60.00% | +30.60 | CTEV | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 3.70% | -1.20% | +4.90 | CTEV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | RPAY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.7 | 61.2 | -14.50 | RPAY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $406.7M | $397.2M | $9.6M | CTEV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTEV REV | RPAY REV | CTEV GROSS % | RPAY GROSS % | CTEV FCF | RPAY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $965.4M | $309.3M | — | 75.0% | -$12.3M | $90.8M |
| FY 2024 | $930.6M | $313.0M | — | 77.1% | -$10.5M | $149.1M |
| FY 2023 | $961.5M | $296.6M | — | — | $171.7M | $103.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTEV // BETA —
RPAY // BETA —